For Pharma
Accelerate drug discovery and clinical development with real-world evidence
Transform Drug Development with AI
SynThera provides pharmaceutical companies with unprecedented access to real-world clinical data, accelerating drug discovery, clinical trials, and regulatory submissions through AI-powered insights.
Unlock the Power of Real-World Evidence
Access anonymized insights from millions of patient encounters across specialties, powering faster, more informed decisions throughout the drug development lifecycle.
Drug discovery timelines
AI-powered biomarker identification
Per successful drug
Reduced clinical trial costs
Success rates
Better patient selection
Real-world data access
Anonymized clinical insights
Applications Across Drug Development
Drug Discovery
- AI-powered target identification
- Biomarker discovery from real-world data
- Drug repurposing opportunities
- Adverse event prediction
Success Story:
Bristol Myers Squibb identified 12 new oncology targets using SynThera's real-world evidence platform
Clinical Trials
- Patient recruitment and matching
- Trial site selection optimization
- Real-world endpoint validation
- Digital biomarker development
Success Story:
Reduced patient recruitment time by 60% for Phase II diabetes trial
Regulatory Affairs
- Real-world evidence generation
- Post-market surveillance
- Safety signal detection
- Regulatory submission support
Success Story:
Accelerated FDA approval process by 8 months with comprehensive RWE package
Flexible Partnership Models
Data Licensing
Access to anonymized clinical datasets
Starting at $500K annually
Based on data scope and usage
Strategic Partnership
Joint research and development
Custom Investment Range
$2M - $50M+ based on scope
Comprehensive Clinical Data Assets
Patient Records
Medical Specialties
Hospital Systems
Longitudinal Data
Clinical Data
- SOAP notes and clinical narratives
- Laboratory results and trends
- Vital signs and monitoring data
- Medication histories and responses
- Diagnostic imaging reports
Outcomes Data
- Treatment effectiveness measures
- Adverse event profiles
- Patient-reported outcomes
- Healthcare utilization patterns
- Long-term survival data
Demographic Data
- Age, gender, ethnicity distributions
- Geographic and socioeconomic factors
- Comorbidity patterns
- Insurance and access data
- Social determinants of health
Pharma Success Stories
Bristol Myers Squibb
Strategic Data Partnership
Challenge:
Accelerating oncology drug discovery and identifying new therapeutic targets
Solution:
Access to 2M+ anonymized cancer patient records with AI-powered biomarker discovery
Results:
"SynThera's real-world evidence platform has fundamentally changed how we approach drug discovery. The insights we're gaining are unprecedented."
— Dr. Sarah Williams, VP of Translational Medicine
Major Pharma Company
Clinical Trial Optimization
Challenge:
Improving patient recruitment and reducing trial timelines for rare disease study
Solution:
AI-powered patient matching and site selection using real-world clinical data
Results:
"The precision of patient matching using SynThera's platform exceeded our expectations and transformed our clinical development process."
— Clinical Development Director
Enterprise-Grade Compliance & Security
Data Privacy
- HIPAA compliant anonymization
- Zero-knowledge architecture
- Differential privacy techniques
- Secure multi-party computation
Regulatory Standards
- FDA 21 CFR Part 11 compliance
- GCP and GLP standards
- ICH E6(R2) guidelines
- GDPR and data sovereignty
Infrastructure Security
- SOC 2 Type II certified
- End-to-end encryption
- Multi-factor authentication
- Audit trails and monitoring
Ready to Accelerate Your Drug Development?
Join leading pharmaceutical companies leveraging SynThera's real-world evidence platform to make faster, more informed decisions throughout the drug development lifecycle.
HIPAA compliant • Enterprise security • Custom partnerships available